SXS.L - Spectris plc
| Previous close | 2,769.00 |
| Open | 2,767.00 |
| Bid | 2,550.00 x 56300 |
| Ask | 0.00 x 20800 |
| Day's range | 2,750.00 - 2,785.00 |
| 52-week range | 2,220.50 - 2,849.00 |
| Volume | 233,867 |
| Avg. volume | 377,577 |
| Market cap | 3.291B |
| Beta | 0.58 |
| PE ratio (TTM) | 14.11 |
| EPS (TTM) | 196.10 |
| Earnings date | 24 Jul 2018 |
| Forward dividend & yield | 0.75 (2.70%) |
| Ex-dividend date | 2018-05-24 |
| 1y target est | 2,873.57 |
- PR Newswire•2 months ago
SPECTRIS PLC - Transaction in Own Shares
Transactions in own shares Spectris plc (the Company ) announces that it has purchased the following number of its ordinary shares of 5 pence on the London Stock Exchange from J.P. Morgan Securities plc ...
- PR Newswire•2 months ago
SPECTRIS PLC - Transaction in Own Shares
Transactions in own shares Spectris plc (the Company ) announces today it has purchased the following number of its ordinary shares of 5 pence on the London Stock Exchange from J.P. Morgan Securities ...
- PR Newswire•2 months ago
SPECTRIS PLC - Transaction in Own Shares
Transactions in own shares Spectris plc (the Company ) announces today it has purchased the following number of its ordinary shares of 5 pence on the London Stock Exchange from J.P. Morgan Securities ...
- PR Newswire•2 months ago
SPECTRIS PLC - Transaction in Own Shares
Transactions in own shares Spectris plc (the Company ) announces today that it purchased the following number of its ordinary shares of 5 pence each on the London Stock Exchange from J.P. Morgan Securities ...
- PR Newswire•2 months ago
SPECTRIS PLC - Transaction in Own Shares
Transactions in own shares Spectris plc (the Company ) announces today that it purchased the following number of its ordinary shares of 5 pence each on the London Stock Exchange from J.P. Morgan Securities ...
- PR Newswire•3 months ago
SPECTRIS PLC - Spectris plc - Share repurchase programme
Spectris plc (the Company) announces that, in connection with the 15 month share buyback programme of up to £100 million which it announced on 19 February 2018, it is commencing a share buyback programme (the Programme) to purchase shares up to a value not exceeding £100 million subject to remaining within the AGM authority (at the 26 May 2017 AGM, shareholders gave the Company authority to purchase a maximum of 11,919,200 ordinary shares) during the period starting on 5 March 2018 and ending no later than 5 June 2019 (the Engagement Period) in order to reduce the capital of the Company. The Company has entered into an agreement with J.P. Morgan Securities plc (JPMS plc) under which it has issued an instruction to JPMS plc to manage the Programme.
- PR Newswire•3 months ago
SPECTRIS PLC - Total Voting Rights
SPECTRIS plc: Voting Rights and Capital In accordance with the FCA’s Disclosure Guidance and Transparency Rule 5.6.1 R, Spectris is updating the market on voting rights and capital at the end of the prior ...
- PR Newswire•3 months ago
SPECTRIS PLC - Holding(s) in Company
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer ...
- Reuters - UK Focus•3 months ago
BUZZ-Spectris: Strong FY results lift stock
** Electrical engineering company up 2.1 pct after co's results beat consensus ** Co reports FY revenue +13 pct to 1.53 bln stg, underlying operating profit up by 17 pct and FY dividend +9 pct to 57 pounds ...
- PR Newswire•4 months ago
SPECTRIS PLC - Total Voting Rights
SPECTRIS plc: Voting Rights and Capital In accordance with the FCA’s Disclosure Guidance and Transparency Rule 5.6.1 R, Spectris is updating the market on voting rights and capital at the end of the prior ...
- Business Wire•4 months ago
Concept Life Sciences Group Acquired by Spectris plc
Concept Life Sciences (‘Concept’), the integrated drug discovery, development and analytical services and environmental consultancy company, today announced the completion of its acquisition by Spectris plc (‘Spectris’), the productivity-enhancing instrumentation and controls company. Spectris has acquired the Concept Life Sciences Group of companies from Equistone Partners and company management, for a purchase consideration of £163 million, on a debt and cash-free basis.
- PR Newswire•5 months ago
SPECTRIS PLC - Total Voting Rights
SPECTRIS plc: Voting Rights and Capital In accordance with the FCA’s Disclosure Guidance and Transparency Rule 5.6.1 R, Spectris is updating the market on voting rights and capital at the end of the prior ...
- PR Newswire•6 months ago
SPECTRIS PLC - Director/PDMR Shareholding
Spectris plc: Director/PDMR Shareholding OPTIONS EXERCISED UNDER THE SPECTRIS SAVINGS RELATED SHARE OPTION SCHEME (THE “SAYE SCHEME”) BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (“PDMRs”) John O’Higgins ...
- PR Newswire•6 months ago
SPECTRIS PLC - Total Voting Rights
SPECTRIS plc: Voting Rights and Capital In accordance with the FCA’s Disclosure Guidance and Transparency Rule 5.6.1 R, Spectris is updating the market on voting rights and capital at the end of the prior ...
- PR Newswire•6 months ago
SPECTRIS PLC - Blocklisting - Interim Review
SPECTRIS plc: Blocklisting Interim Review Name of applicant: Spectris plc Period of return: June 2017 to November 2017 The total number of shares in issue at the end of the period (excluding the total ...
- PR Newswire•7 months ago
SPECTRIS PLC - Total Voting Rights
SPECTRIS plc: Voting Rights and Capital In accordance with the FCA’s Disclosure Guidance and Transparency Rule 5.6.1 R, Spectris is updating the market on voting rights and capital at the end of the prior ...
- PR Newswire•8 months ago
SPECTRIS PLC - Total Voting Rights
SPECTRIS plc: Voting Rights and Capital In accordance with the FCA’s Disclosure Guidance and Transparency Rule 5.6.1 R, Spectris is updating the market on voting rights and capital at the end of the prior ...